Products with Anticancer bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3823 | Methyl gallate |
| Methyl Gallate is a plant polyphenol with antioxidant, anticancer, anti-bacterial, and anti-inflammatory activities.Methyl gallate is a potent and highly specific inhibitor of herpes simplex virus in vitro. Methyl gallate also has a dual cyclooxygenase-2/5-lipoxygenase inhibitory activity. Methyl gallate can inhibit the growth of oral pathogens and S. mutans biofilm formation, and may be used to prevent the formation of oral biofilms. | |
| BCN3835 | Kukoamine A |
| 1. Kukoamine A shows hypotensive activity. | |
| BCN3840 | Diallyl disulfide |
| Diallyl disulfide has antitumor effect, the effect can be enhanced by miR-200b and miR-22. Diallyl disulfide induces antioxidant defense mechanism by activating Nrf2 pathway and reduces inflammatory response by inhibiting NF-κB activation. Diallyl disulfide also has protective effect against CP-induced developmental toxicity. | |
| BCN3861 | Polygalacin D |
| 1. Polygalacin D can inhibit the expression of lipopolysaccharide (LPS)-induced iNOS and COX-2 protein and mRNA without an appreciable cytotoxic effect on RAW 264.7 macrophages, and can suppress induction by LPS of pro-inflammatory cytokines such as prostaglandin E2 (PGE2). 2. Polygalacin D2 exhibits significant inhibition on the proliferation of five kinds of cultured human tumor cell lines, i. e., A549 (non-small cell lung), SK-OV-3 (ovary), SK-MEL-2 (melanoma), XF498 (central nerve system) and HCT-15 (colon), in vitro. 3. Polygalacin D shows hepatoprotective activities against HSC-T6 cell line in vitro. | |
| BCN3862 | Escin IA |
| Escin IA is a prodrug and its structure can be converted to desacylescin I by human intestinal bacteria and Lactobacillus brevis., desacylescin I as a biotransformation product shows potentially inhibitory effects on mouse tumor, and a potential candidate for anti tumor agents. Escin IA has anti-TNBC metastasis activity, and its action mechanisms involved inhibition of EMT process by down-regulating LOXL2 expression. | |
